Continuing my role as a lawyer explaining law to non-lawyers, here's what's known as a "case note" on the Bell v Tavistock litigation, which concerned whether persons under the age of 16 were able to consent to treatment with puberty blockers and cross-sex hormones as part of gender transition. Among other things, the case revealed serious weaknesses in the evidence base for transgender medicine.